GlyCLICK® for Highly Homogeneous ADCs

Characterization of GlyCLICK®-generated Antibody-Drug Conjugates (ADCs) Using Orthogonal icIEF-UV/MS and LC/MS Workflows | CASSS CE Pharm (2026)

Please fill out the form to access and download the file

Don't hesitate to contact us if you experience any problems with this feature.

First Name Last Name Email Phone Country Company I agree to get the latest news and offers

By providing us with your contact details, you accept our Data Protection Policy.

Required field

Generation of Highly Potent ADCs using GlyCLICK®
Application
Site-specific ADC generation with defined DAR, preserving antigen binding and delivering potent, controlled cytotoxicity in target cells.